Does urinary neurotransmitter testing reflect brain neurotransmitter levels?

No. The blood–brain barrier prevents most neurotransmitters from equilibrating between brain and periphery, so urinary levels reflect systemic and peripheral metabolism rather than direct central nervous system activity. Interpretation is exploratory and used within functional frameworks.

When is a neurotransmitter panel ordered?

Practitioners order it in functional psychiatry to explore biochemical patterns in treatment-resistant mood disorders, anxiety, insomnia, fatigue, attention deficits, and suspected histamine intolerance, and to guide targeted amino-acid or cofactor supplementation.

What interferes with neurotransmitter test results?

Dietary protein and biogenic amines, medications (antidepressants, stimulants, beta-blockers), stress, exercise, time of day, gut dysbiosis, and renal function all affect results. A full history of diet, supplements, medications, and stress at the time of collection is essential.

Can this test diagnose psychiatric or neurological disorders?

No. The test is exploratory and used in functional medicine to guide interventions; it is not a validated diagnostic tool for psychiatric or neurological disease. Psychiatric diagnosis rests on clinical criteria, and neurological investigation requires evidence-based neuroendocrine and imaging studies.

What does elevated catecholamine excretion mean?

Elevated dopamine, norepinephrine, or epinephrine can reflect stress, anxiety, sympathetic hyperactivity, stimulant use, or, if clinical features suggest it, a catecholamine-secreting tumour. If phaeochromocytoma is suspected, follow with plasma-free metanephrines, the validated screening test.

How long do results take?

Results are typically available 10–14 business days from specimen receipt at Doctor's Data.

BML-NMH-003neurological mental healthUSA

Comprehensive Neurotransmitter Add-On - Random

Q: Is fasting or special preparation required?

Fasting is not required, though practitioners often recommend avoiding high-protein meals, fermented foods, and strenuous exercise for 12 hours before collection to reduce dietary and stress interference. The sample is a random-spot collection, typically mid-morning.

The Comprehensive Neurotransmitter Add-On measures urinary serotonin, dopamine, norepinephrine, epinephrine, GABA, glutamate, glycine, and histamine in a random-spot sample. It is a functional-medicine tool used to explore peripheral neurotransmitter metabolism in mood, anxiety, sleep, and stress-related conditions, guiding amino-acid and cofactor interventions, though it does not reflect…

Biomarkers

Urine (random)

Sample

10–14 business days

Turnaround

Fasting

What is the Neurotransmitter Add-On test?

The Comprehensive Neurotransmitter Add-On measures urinary concentrations of eight neuroactive compounds — serotonin, dopamine, norepinephrine, epinephrine, GABA, glutamate, glycine, and histamine — using random-spot urine and creatinine normalisation. It is positioned in functional and integrative psychiatry as a tool to explore biochemical underpinnings of mood, anxiety, sleep, attention, and stress-related symptoms, and to guide nutrient, cofactor, and amino-acid interventions. The test reflects peripheral and systemic neurotransmitter metabolism rather than direct central nervous system activity, because the blood–brain barrier excludes most neuroactive compounds from equilibrating between brain and periphery. Practitioners interpret patterns — serotonin and GABA as markers of calming tone, dopamine and norepinephrine as drive and arousal, glutamate as excitatory load — within a functional framework that views biochemical imbalances as modifiable through diet, supplementation, and lifestyle. The panel is exploratory, not diagnostic, and should be distinguished from validated neuroendocrine tests such as 24-hour urinary catecholamines for phaeochromocytoma or plasma metanephrines for tumour screening.

What does the Neurotransmitter Add-On test measure?

5-HT(Serotonin)

Range: Laboratory-specific; typically 50–250 µg/g creatinine in random urine.Optimal: Functional practitioners often target mid-range values, though no consensus optimal exists; clinical correlation is essential.µg/g creatinine / nmol/mmol creatinine

Serotonin is synthesised from tryptophan in enterochromaffin cells and serotonergic neurones, where it modulates mood, sleep, appetite, and gastrointestinal motility. Peripheral serotonin predominates, with only a small fraction crossing the blood–brain barrier. Urinary serotonin reflects both central and peripheral turnover, though the majority derives from gut sources.

Urinary serotonin is used to explore mood dysregulation, sleep disturbance, and appetite abnormalities in functional and integrative practice. Elevated levels may suggest carcinoid tumour when accompanied by clinical features; low values are interpreted as a marker of inadequate substrate or cofactor availability in functional frameworks.

DA(Dopamine)

Range: Laboratory-specific; typically 150–600 µg/g creatinine in random urine.Optimal: Functional interpretations favour mid-to-upper-normal values, though this is exploratory and not diagnostically validated.µg/g creatinine / nmol/mmol creatinine

Dopamine is a catecholamine synthesised from tyrosine via DOPA, acting as both a neurotransmitter in reward, motivation, and motor pathways and a peripheral hormone. Urinary dopamine reflects whole-body turnover, with contributions from the sympathetic nervous system, adrenal medulla, and renal tubular synthesis.

Practitioners order urinary dopamine to assess drive, motivation, and reward processing in functional psychiatry, and to screen for catecholamine-secreting tumours when clinical suspicion is high. Low levels are framed as indicating inadequate synthesis or cofactor deficiency in integrative models.

NE(Norepinephrine)

Range: Laboratory-specific; typically 15–80 µg/g creatinine in random urine.Optimal: Mid-range values are preferred in functional models, though evidence-based thresholds do not exist.µg/g creatinine / nmol/mmol creatinine

Norepinephrine is synthesised from dopamine in sympathetic nerve terminals and the adrenal medulla, mediating the fight-or-flight response, attention, and arousal. Urinary excretion reflects sympathetic nervous system activity and adrenal output, with marked variability tied to stress, posture, and circadian rhythm.

Urinary norepinephrine is used to evaluate sympathetic tone, chronic stress responses, and attention deficits in functional practice, and to screen for phaeochromocytoma in appropriate clinical contexts. Elevated values suggest hyperarousal or tumour; low values are interpreted as adrenal insufficiency or autonomic dysfunction in integrative frameworks.

Epi(Epinephrine)

Range: Laboratory-specific; typically 2–20 µg/g creatinine in random urine.Optimal: Functional practitioners interpret low-normal to mid-range as optimal, though clinical validation is lacking.µg/g creatinine / nmol/mmol creatinine

Epinephrine is synthesised in the adrenal medulla from norepinephrine via phenylethanolamine N-methyltransferase, a cortisol-dependent enzyme. It is the principal adrenal catecholamine, driving metabolic and cardiovascular responses to acute stress. Urinary epinephrine excretion is highly variable and stress-sensitive.

Urinary epinephrine helps assess acute stress responses and adrenal reserve in functional medicine and screens for adrenal medullary tumours. Elevated levels suggest anxiety, hyperarousal, or phaeochromocytoma; low values are attributed to adrenal fatigue or dysautonomia in integrative practice.

GABA(Gamma-Aminobutyric Acid)

Range: Laboratory-specific; typically 1–5 µg/g creatinine in random urine.Optimal: Mid-range values are considered optimal in functional frameworks, though evidence supporting this interpretation is exploratory.µg/g creatinine / nmol/mmol creatinine

GABA is the principal inhibitory neurotransmitter in the central nervous system, synthesised from glutamate by glutamic acid decarboxylase. Peripheral GABA is produced in gut, pancreas, and other tissues. Urinary GABA originates almost entirely from peripheral sources, as the blood–brain barrier excludes central GABA from systemic circulation.

Urinary GABA is used in functional psychiatry to explore anxiety, insomnia, and inhibitory tone, though its peripheral origin limits inference about central nervous system function. Low levels are interpreted as inadequate calming neurotransmission in integrative models.

Glu(Glutamate)

Range: Laboratory-specific; typically 5–50 µg/g creatinine in random urine.Optimal: Functional models favour balanced glutamate-to-GABA ratios, though optimal thresholds are not established.µg/g creatinine / nmol/mmol creatinine

Glutamate is the primary excitatory neurotransmitter, synthesised from glutamine and alpha-ketoglutarate. It plays central roles in synaptic plasticity, learning, and memory. Urinary glutamate reflects peripheral metabolism and dietary intake, with negligible contribution from the central nervous system due to blood–brain barrier exclusion.

Practitioners order urinary glutamate to assess excitatory tone and excitotoxicity risk in functional psychiatry and neurology. Elevated levels are framed as indicating excess excitation or inadequate GABA balance; low levels suggest poor substrate availability. The peripheral origin of urinary glutamate limits direct inference about brain activity.

Gly(Glycine)

Range: Laboratory-specific; typically 50–300 µg/g creatinine in random urine.Optimal: Mid-to-upper-normal values are preferred in functional practice, without robust evidence.µg/g creatinine / nmol/mmol creatinine

Glycine is the simplest amino acid and an inhibitory neurotransmitter in the spinal cord and brainstem, modulating motor and sensory pathways. It also serves as a co-agonist at NMDA receptors, supporting excitatory signalling. Urinary glycine reflects whole-body amino-acid metabolism, detoxification conjugation reactions, and dietary intake.

Urinary glycine is measured in functional neurology to explore inhibitory signalling and detoxification capacity. Low levels are interpreted as compromised conjugation or inadequate synthesis, though clinical significance is exploratory and not diagnostically validated.

His(Histamine)

Range: Laboratory-specific; typically 10–100 µg/g creatinine in random urine.Optimal: Functional practitioners interpret low-to-mid-range as optimal, though evidence is limited and contested.µg/g creatinine / nmol/mmol creatinine

Histamine is synthesised from histidine by histidine decarboxylase in mast cells, basophils, enterochromaffin-like cells, and neurones. It mediates allergic responses, gastric acid secretion, and neuromodulation. Urinary histamine reflects systemic release and turnover, predominantly from peripheral sources.

Urinary histamine is ordered to investigate mast cell activation, histamine intolerance, and allergic burden in functional and allergy-focused practices. Elevated levels suggest mast-cell degranulation or impaired degradation; normal or low values do not exclude intolerance, as tissue and plasma compartments may not equilibrate with urine.

Why is the Neurotransmitter Add-On test ordered?

Functional psychiatry evaluation of treatment-resistant mood disorders, where conventional approaches have been exhausted and a biochemical exploration is desired
Assessment of patients with chronic fatigue, poor motivation, or anhedonia, to explore catecholamine and serotonin synthesis and turnover
Investigation of anxiety, insomnia, or hyperarousal in patients interested in targeted amino-acid or cofactor interventions
Evaluation of suspected histamine intolerance or mast-cell activation, interpreted alongside clinical symptoms and dietary triggers
Monitoring the biochemical response to amino-acid precursors (5-HTP, L-tyrosine, L-theanine) or cofactor supplementation (B6, folate, magnesium) in functional protocols
Assessment of attention-deficit symptoms in integrative paediatric or adult practice, where nutrient and neurotransmitter support is part of the treatment plan
Exploration of autonomic imbalance or dysautonomia in chronic illness, where catecholamine patterns may inform stress and arousal management

Sample collection and turnaround

Sample type

Urine (random)

Fasting required

Collection method

At-home collection kit

Turnaround

10–14 business days

Collection notes

Patient collects a random-spot urine sample using the kit supplied by Doctor's Data, typically mid-morning to minimise extreme circadian effects. Practitioners often recommend avoiding high-protein meals, fermented foods, and strenuous exercise for 12 hours before collection to reduce dietary and stress-related interference, though no strict fasting protocol is mandated. The sample is returned by courier per kit instructions.

Specimen requirements

Minimum 10 mL random urine in the provided preservative-free container. Refrigerate immediately after collection if not shipping the same day. Creatinine is measured to normalise analyte concentrations. Note any medications, supplements (especially amino acids, 5-HTP, L-tyrosine, or cofactors), and recent stress or exercise on the requisition form.

What can affect Neurotransmitter Add-On results?

elevatesDietary intake of precursor amino acids and biogenic amines

Tryptophan, tyrosine, and histidine from protein-rich meals, and dietary histamine from fermented or aged foods, raise urinary neurotransmitter metabolites independently of endogenous synthesis.

variableMedications affecting neurotransmitter synthesis or metabolism

Antidepressants (SSRIs, SNRIs, MAOIs), stimulants, beta-blockers, and L-DOPA alter neurotransmitter turnover and urinary excretion; a full medication history is essential to interpretation.

variableTime of collection and circadian rhythm

Catecholamine and serotonin excretion follow circadian patterns and stress responsiveness; random-spot samples capture a single time point and may not reflect diurnal or stress-averaged values.

elevatesStress, exercise, and sympathetic activation

Acute psychological or physical stress markedly raises catecholamine excretion; results should be interpreted in the context of the patient's state at the time of collection.

variableRenal function and urine dilution

Creatinine normalisation adjusts for concentration, but severe renal impairment or very dilute or concentrated urine may distort ratios; first morning void or 24-hour collection is more reproducible but not used in this random protocol.

variableGut dysbiosis and microbial neurotransmitter production

Gut microbiota synthesise GABA, serotonin precursors, and other neuroactive compounds; dysbiosis may alter urinary profiles independently of host synthesis, complicating interpretation.

What do Neurotransmitter Add-On results mean?

Elevated

Elevated serotonin: carcinoid syndrome (if accompanied by flushing, diarrhoea, wheezing) or high dietary tryptophan. Elevated catecholamines (dopamine, norepinephrine, epinephrine): stress, anxiety, sympathetic hyperactivity, stimulant use, or catecholamine-secreting tumour (phaeochromocytoma, paraganglioma) — if clinical suspicion is high, follow with plasma-free metanephrines. Elevated glutamate: high dietary intake or, in functional models, excitotoxicity risk. Elevated histamine: mast-cell activation, histamine intolerance, or high dietary histamine load.

Normal

Normal values do not exclude central nervous system neurotransmitter imbalances, as urinary levels reflect peripheral turnover and do not equilibrate with brain concentrations. A normal panel in a symptomatic patient should prompt consideration of receptor function, reuptake dynamics, or other neurobiological mechanisms not captured by urinary metabolite measurement.

Reduced

Low serotonin: in functional frameworks, inadequate tryptophan or cofactor (B6, folate, magnesium) availability; not a validated diagnostic marker. Low catecholamines: adrenal insufficiency, autonomic dysfunction, or inadequate tyrosine and cofactor supply in integrative models. Low GABA: insufficient GAD activity or glutamate substrate, interpreted as reduced inhibitory tone. Low glycine: poor synthesis or detoxification capacity, exploratory only.

Note: This panel measures peripheral neurotransmitter metabolism, not central nervous system activity; the blood–brain barrier prevents equilibration. Interpretation is exploratory and rooted in functional medicine frameworks rather than evidence-based diagnostic criteria. Elevated catecholamines warrant clinical correlation and, if tumour is suspected, follow-up with plasma metanephrines. Dietary, medication, stress, and microbial factors profoundly affect results, so patterns should be interpreted in full clinical context and not used in isolation to diagnose psychiatric or neurological disease.

Frequently asked questions

The test measures urinary concentrations of eight neuroactive compounds — serotonin, dopamine, norepinephrine, epinephrine, GABA, glutamate, glycine, and histamine — normalised to creatinine, to explore peripheral neurotransmitter metabolism and turnover.

How to access the Neurotransmitter Add-On test

The Neurotransmitter Add-On reference page is free and open to all practitioners. Create a free practitioner account to see pricing, save tests to your list, and generate requisition forms. Verification takes 1–2 business days.

Create Free Account

About this page

Published: October 7, 2026

Last reviewed: October 7, 2026

References:

Eisenhofer G, et al. Biochemical diagnosis of phaeochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab. (2003)
Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. (2012)
Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. (2007)
Hinz M, Stein A, Uncini T. Amino acid management of Parkinson's disease: a case study. Int J Gen Med. (2011)

This content is for licensed healthcare practitioners only and does not constitute medical advice. Clinical decisions should be based on the full clinical picture and not on any single test result.